Skip to content
  • About us
    • Advisory Board
    • Our mission
    • GDPR Policy
  • Editorial guidelines
    • Peer-review protocol
    • Author guidelines
    • Editorial Calendar 2018
    • Editorial Calendar 2017
  • Advertise with us
    • Media Information 2021
    • Media Information 2020
  • Subscribe
    • weekly newsletter
  • Contact Us
secondary menu
Journal for Clinical Studies
Journal for Clinical StudiesJournal for Clinical Studies
 

 

  • Home
  • Current features/ Volume 13 Issue 1
  • Editorial Archive
    • Volume 12 Issue 6
    • Volume 12 Issue 5
    • Volume 12 Issue 4
    • Volume 12 Issue 3
    • Volume 12 Issue 2
    • Volume 12 Issue 1
    • Volume 11 Issue 6
    • Volume 11 Issue 5
    • Volume 11 Issue 4
    • Volume 11 Issue 3
    • Volume 11 Issue 2
    • Volume 11 Issue 1
    • Volume 10 Issue 6
    • Volume 10 Issue 5
    • Volume 10 Issue 4
    • Volume 10 Issue 3
    • Volume 10 Issue 2
    • Volume 10 Issue 1
    • Volume 9 Issue 6
      • Volume 10 Issue 6
    • Volume 9 Issue 5
    • Volume 9 Issue 4
    • Volume 9 Issue 3
    • Volume 9 Issue 2
    • Volume 9 Issue 1
      • Regulatory V9 I1
      • Market Report V9 I1
      • Therapeutics V9 I1
      • IT & Logistics V9 I1
    • Volume 8 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Technology
      • Therapeutics
      • Special Features
      • Logistics
    • Volume 8 Issue 5
      • Watch Pages V8 I5
      • Regulatory V8 I5
      • Market Report V8 I5
      • Technology V8 I5
      • Therapeutics V8 I5
      • Special Features V8 I5
      • Logistics V8 I5
    • Volume 8 Issue 4
      • Watch Pages V8 I4
      • Regulatory V8 I4
      • Market Report V8 I4
      • Therapeutics V8 I4
      • Technology V8 I4
      • Logistics V8 I4
      • Special Feature V8 I4
    • Volume 8 Issue 3
      • Watch Pages V8 I3
      • Regulatory V8 I3
      • Market Report V8 I3
      • Therapeutics V8 I3
      • Technology V8 I3
      • Logistics V8 I3
      • Special Feature V8 I3
    • Volume 8 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 8 Issue 1
    • Volumen 8 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 issue 3
      • Watch Pages
      • Therapeutics
      • Research & Development
      • Regulatory & Marketplace
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 7 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 6 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • It & Logistics
      • Special Features
    • Volume 6 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 5 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • It & Logistics
      • Therapeutics
      • Special Features
    • Volume 5 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 5 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Feature
    • Volume 5 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
  • Archived Issues
  • Industry events
  • Company Profile
    • A-D
    • E-M
    • N-S
    • T-Z
  • Regional News
    • Asia Pacific
    • Australasia
    • Europe
    • Latin America
    • MEANA Region
    • North America
    • Russia/Eastern Europe
    • Scandinavia
    • South Africa
    • Sub Saharan Africa
  • eBooks
  • Podcast
  • Home
  • Current features/ Volume 13 Issue 1
  • Editorial Archive
    • Volume 12 Issue 6
    • Volume 12 Issue 5
    • Volume 12 Issue 4
    • Volume 12 Issue 3
    • Volume 12 Issue 2
    • Volume 12 Issue 1
    • Volume 11 Issue 6
    • Volume 11 Issue 5
    • Volume 11 Issue 4
    • Volume 11 Issue 3
    • Volume 11 Issue 2
    • Volume 11 Issue 1
    • Volume 10 Issue 6
    • Volume 10 Issue 5
    • Volume 10 Issue 4
    • Volume 10 Issue 3
    • Volume 10 Issue 2
    • Volume 10 Issue 1
    • Volume 9 Issue 6
      • Volume 10 Issue 6
    • Volume 9 Issue 5
    • Volume 9 Issue 4
    • Volume 9 Issue 3
    • Volume 9 Issue 2
    • Volume 9 Issue 1
      • Regulatory V9 I1
      • Market Report V9 I1
      • Therapeutics V9 I1
      • IT & Logistics V9 I1
    • Volume 8 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Technology
      • Therapeutics
      • Special Features
      • Logistics
    • Volume 8 Issue 5
      • Watch Pages V8 I5
      • Regulatory V8 I5
      • Market Report V8 I5
      • Technology V8 I5
      • Therapeutics V8 I5
      • Special Features V8 I5
      • Logistics V8 I5
    • Volume 8 Issue 4
      • Watch Pages V8 I4
      • Regulatory V8 I4
      • Market Report V8 I4
      • Therapeutics V8 I4
      • Technology V8 I4
      • Logistics V8 I4
      • Special Feature V8 I4
    • Volume 8 Issue 3
      • Watch Pages V8 I3
      • Regulatory V8 I3
      • Market Report V8 I3
      • Therapeutics V8 I3
      • Technology V8 I3
      • Logistics V8 I3
      • Special Feature V8 I3
    • Volume 8 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 8 Issue 1
    • Volumen 8 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 issue 3
      • Watch Pages
      • Therapeutics
      • Research & Development
      • Regulatory & Marketplace
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 7 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 6 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • It & Logistics
      • Special Features
    • Volume 6 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 5 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • It & Logistics
      • Therapeutics
      • Special Features
    • Volume 5 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 5 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Feature
    • Volume 5 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
  • Archived Issues
  • Industry events
  • Company Profile
    • A-D
    • E-M
    • N-S
    • T-Z
  • Regional News
    • Asia Pacific
    • Australasia
    • Europe
    • Latin America
    • MEANA Region
    • North America
    • Russia/Eastern Europe
    • Scandinavia
    • South Africa
    • Sub Saharan Africa
  • eBooks
  • Podcast

Tag Archives: nanobiotix

NANOBIOTIX ANNOUNCES POSITIVE PHASE II/III TOPLINE DATA IN SOFT TISSUE SARCOMA WITH NBTXR3

EuropeBy flabio527th June 2018

Trial achieved its primary endpoint of pathological Complete Response Rate Trial achieved its secondary endpoint in operability (R0 rate) NBTXR3…

Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers

EuropeBy flabio59th May 2018

NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced…

The University of Texas Md Anderson Cancer Center and Nanobiotix have an agreement to run Immunotherapeutic Pre-Clinical Research in Lung Cancer combining Nbtxr3 and Nivolumab

Europe, North AmericaBy flabio511th April 2018

 NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today…

© 2020 Jforcs Media, All Rights Reserved. Powered by Teksyte LTD
Go to Top